A Phase 1/2 interventional study of Task-oriented resistance exercise in Mobility Limitation and Cognitive Impairment, sponsored by University of Florida. Recruiting at 2 sites in United States. Open to participants aged 65 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-07-31.
Sponsored by University of Florida · Phase 1/2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 126 studies in Mobility Limitation with a site in United States — 31 open to participants now, 35 under way, 3 of them phase 3. Mobility Limitation · United States.
Among the 126 studies in Mobility Limitation with a site in United States, this one is the 101st largest by planned enrollment of the 116 interventional ones that give a count, is one of 10 that started in 2026, is one of 2 in phase 1/2, reaches primary completion later than 5 of the 34 other live ones, and was the 116th registered.
383 studies on the registry are indexed under Mobility Limitation; 106 are open to participants now.
Browse Mobility Limitation studies →31 of the 126 studies in Mobility Limitation with a site in United States are open now. Recruiting first, the newest first:
RxFunction Inc. · Sites in United States
Ages 60+
St. Jude Children's Research Hospital · Sites in United States
Ages 5–20 · Healthy volunteers
Wake Forest University Health Sciences · Sites in United States
Ages 18+
The University of Alabama in Huntsville · Sites in United States
Ages 65+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 65 Mobility Limitation studies recruiting now, 33 (51%) set no upper age limit and 15 (23%) stop at 75 or younger; 5 take children under 18; 9 take healthy volunteers.
This study: 65 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
126 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 11 · Phase 3 9
First in 1997; this study’s year is marked. 10 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 46 across 318 interventional studies indexed under Mobility Limitation.
Median enrollment 40 across the 116 interventional studies, 92 across the 10 observational. Of the 83 that completed or were terminated, 30 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 126 have an industry lead sponsor. The 10 most frequent:
University of Florida is the lead sponsor of 1,290 studies on the registry; 202 are open to participants now.
Of its 181 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.
University of Florida has 6 studies filed under Mobility Limitation — fewer than ten, so there is no comparison to draw.
13 of the studies in Mobility Limitation with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07125378University of FloridaLiving Independence Through Functional Training | 2026-11-30 |
| NCT05725564Milton S. Hershey Medical CenterTesting Interventions for Mobility Through Exercise (TIME) | 2026-12 |
| NCT06484244Emory UniversityLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease | 2026-12-31 |
| NCT05661084Hebrew SeniorLifeNon-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia | 2026-12-31 |
| NCT07337317The University of Alabama in HuntsvilleEvaluating Stairway Designs for Individuals With Vision Impairment | 2027-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 126 studies in Mobility Limitation with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the research is to evaluate the feasibility and benefits of a six-week hybrid task-oriented resistance exercise program for older adults who have been recently discharged from home health care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive a task-oriented resistance exercise program at home.
Behavioral: Task-oriented resistance exercise
The intervention program includes progressive resistance exercise and daily activity exercise, delivered over a six-week period with an ideal frequency of three sessions per week. Progressive resistance exercise will be provided through a combination of in-person and online sessions, while daily activity exercise will be delivered exclusively in person.
Short Physical Performance Battery
The score ranges from 0 to 12, with a score of 12 indicating the best physical functioning of the lower extremity.
Time frame: Baseline, 8 weeks, and 12 weeks.
Montreal Cognitive Assessment
The score ranges from 0 to 30, with a score of 30 indicating the best global cognitive function.
Time frame: Baseline, 8 weeks, and 12 weeks.
Timed Up and Go Test-Single Task.
Time in seconds to complete the test, with a longer time indicating poor functional mobility.
Time frame: Baseline, 8 weeks, and 12 weeks.
Timed Up and Go-Dual Task
Time in seconds to complete the task, a longer time indicating the interference of the dual task effect on mobility.
Time frame: Baseline, 8 weeks, and 12 weeks.
List Sorting Working Memory Test
The raw score ranges from 0 to 24, with a higher score indicating better working memory. The raw score is converted to a Change Sensitive Score.
Time frame: Baseline, 8 weeks, and 12 weeks.
Dimensional Change Card Sort Test
The raw score ranges from 0 to 30, with a higher score indicating better executive function. The raw score is converted to a Change Sensitive Score.
Time frame: Baseline, 8 weeks, 12 weeks.
Flanker Inhibitory Control and Attention Test
The raw score ranges from 0 to 30, with a higher score indicating better executive function and attention. The raw score is converted to a Change Sensitive Score.
Time frame: Baseline, 8 weeks, and 12 weeks
Pattern Comparison Processing Speed Test
The raw score ranges from 0-133, with a higher score indicating better processing speed. The raw score is converted to a Change Sensitive Score.
Time frame: Baseline, 8 weeks, and 12 weeks
Speeded Matching Test
The score ranges from 0 to 130, with a higher score indicating better speed of processing. The raw score is converted to a Change Sensitive Score.
Time frame: Baseline, 8 weeks, 12 weeks
Oral Symbol Digit Test
The raw score ranges from 0 to 143, with a higher score indicating better processing speed. The raw score is converted to a Rasch score.
Time frame: Baseline, 8 weeks, and 12 weeks
Patient Health Questionnaire-9
The score ranges from 0 to 27, with a higher score indicating a higher degree of depression.
Time frame: Baseline, 8 weeks, 12 weeks.
Pain, Enjoyment of Life and General Activity Scale
The score ranges from 0 to 10, with a higher score indicating greater pain and interference with life by pain.
Time frame: Baseline, 8 weeks, and 12 weeks.
Activity Measure for Post-Acute Care to measure everyday activity performance
The score ranges from 0 to 71, with a higher score indicating better mobility, daily activity function, or daily cognitive ability.
Time frame: Baseline, 8 weeks, and 12 weeks.
Step counts
The number of step counts, a higher number indicates a higher level of physical activity.
Time frame: From enrollment to the end of intervention at 8 weeks.
Sleep efficiently
A ratio score of total sleep time divided by total time in bed per night, ranging from 0 to 1. A higher score indicates better sleep quality.
Time frame: From enrollment to the end of the intervention at 8 weeks.
Program satisfaction
A score ranges from 0 to 6, with a higher score indicating higher satisfaction.
Time frame: 8 weeks
Plan to share: Yes — All IPD that underlie the results in a publication
Time frame: Data requests can be submitted starting 3 months after article publication, and the data will be made accessible for up to 12 months.
Access criteria: Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and able to provide a research proposal and data usage agreement. Please contact the trial principal investigator.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Nov 2026, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.